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A b s t r a c t
Introduction: Deprescribing is the process of tapering or stopping medica-
tions aiming at improving patient outcomes and optimising current therapy. 
Some studies have tried to identify which patients will have inappropriate 
medication deprescribed, but none have found any association with socio-
demographic and clinical characteristics, number of prescribed medications 
or duration of medication. Our aim was to determine Portuguese elderly pa-
tients’ attitudes and beliefs regarding medication use and their willingness 
to have regular medications deprescribed.
Material and methods: We conducted a  cross-sectional study in triangu-
lation in primary care centres from mainland Portugal and its autonomous 
regions. We used a  random sample of 386 polymedicated older adult pa-
tients who answered the questionnaire between October 2018 and February 
2019. For the quantitative analysis, we used sociodemographic characteris-
tics, clinical profile and medication. For the qualitative analysis, we studied 
an included open question by coding participants’ answers; common codes 
were grouped together. A convergent mixed methods design was used.
Results: 74.0% expressed the belief that medicines were generally benefi-
cial. 19.9% reported a strong belief that medicines were harmful and 33.4% 
that they were overused. 61.8% were against the idea of deprescribing and 
24.6% were in favour of deprescription. Those against the idea had a lower 
education level (p = 0.006) and a higher number of self-perceived morbidi-
ties (p = 0.001) than those not against it.
Conclusions: Medication benefits were accepted by the majority of patients 
who also were against the idea of deprescribing. It is important that doctors 
are aware of this reality, namely in the primary care setting, addressing the 
patients’ fears and beliefs and making the deprescribing process possible. 
Key words: deprescription, aged, polypharmacy, patient acceptance of 
health care.
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Introduction
The prevalence of potentially inappropriate 
medications (PIMs) has been described as 68.6% 
of Portuguese elderly patients (≥ 65 years) in the 
primary care setting [1].
Deprescribing is the process of tapering or 
stopping medications with the aim of improving 
patient outcomes and optimizing current therapy 
[2]. Some studies have been performed in order 
to identify which patients will have inappropriate 
medication deprescribed; none found any associa-
tion between age, gender, education level, general 
health status, previous attempt of deprescribing 
the number of medicines or its length of use and 
the success of the deprescribing process [3–5]. 
One of the barriers to deprescribing in the primary 
care setting is the lack of time in the consultation 
[6, 7]. Therefore, creating an accurate profile of 
patients who are willing to have medication de-
prescribed is critical to improve clinical efficiency. 
The Beliefs about Medicines Questionnaire [8] 
is composed of two sections: the General section 
(BMQ-General), which assesses more general 
beliefs about medicines and includes the overall 
perception of Harm (General-Harm subscale) and 
Overuse (General-Overuse subscale) of medi-
cation; and the Specific section (BMQ-Specific), 
which assesses beliefs about a  particular med-
ication and explores the needs (Specific-Neces-
sity subscale) and concerns (Specific-Concern 
subscale) perceived about the medication. This 
questionnaire is cross-culturally validated for the 
Portuguese population [9]. 
The aim of this study was to determine Portu-
guese elderly patients’ attitudes and beliefs re-
garding medication use and their willingness to 
have regular medications deprescribed. The only 
previous study about the elderly patients’ beliefs 
regarding medication use was the cross-cultural 
adaptation of the Beliefs about Medicines Ques-
tionnaire into Portuguese [9]. 
Material and methods
Study design
Cross-sectional study-details, definitions and 
methods were previously published [10]. We ad-
opted a  convergent mixed methods design [11]. 
Secondary analysis of available quantitative and 
qualitative data was conducted separately as de-
scribed below, and the findings were triangulated 
during the interpretation stage [11, 12].
The study was performed in agreement with 
the principles of the Declaration of Helsinki [13] 
and received ethical approval from the University 
of Beira Interior and Portuguese healthcare ad-
ministrative five regions Institutional Ethics Com-
mittees. The reporting of this study conforms to 
the Strengthening the Reporting of Observational 
Studies in Epidemiology (STROBE) statement [14]. 
Setting
The study was carried out in randomly select-
ed primary care health centres in Portugal that 
agreed to participate from the five mainland Por-
tuguese healthcare administrative regions and 
two autonomous regions (Madeira and Azores) 
according to a protocol previously published [10].
Sampling
Since the prevalence of polypharmacy in the 
elderly population in Portugal is 77% [15], we esti-
mated a sample of a minimum 385 patients with 
polypharmacy for a 95% CI and a maximum preci-
sion error of 5%.
Assuming that a general practitioner (GP) would 
be able to include at least 6 patients, a  total of 
65 GPs were invited to participate in this study. 
The GPs were randomly selected from existing files 
of previous projects’ adherent GPs, in other epide-
miological studies, for a higher adherence rate.
Data collection procedures
The invitation of GPs and the recruitment of pa-
tients occurred between October 2018 and Febru-
ary 2019. The GPs were individually instructed to 
give the questionnaire and the informed consent 
to all elderly patients with polypharmacy, equal to 
or more than five drugs per day, attending a prima-
ry care consultation during 6 randomized consulta-
tion days selected for the month after their agree-
ment to collaborate. The GPs were responsible for 
explaining the study, answering patients’ doubts, 
delivering the questionnaire and the informed con-
sent and collecting them. Exclusion criteria were 
being acutely unwell in the previous three weeks, 
recruiting GPs having been instructed to verify 
whether a sudden disease or acute health condi-
tion (such as infectious, painful or inflammatory 
episodes) medication had been prescribed in such 
a period of time, and refusal to participate.
Quantitative data collection and analysis
A  questionnaire designed to collect socio-de-
mographic information such as age, gender 
(male/female), area of residence (the health ad-
ministrative region), perceived number of chron-
ic health problems and auto-referred number of 
daily medications was used in the study. We used 
the Portuguese adapted version of Beliefs about 
Medicines Questionnaire-General (BMQ-General) 
[9]. Some researchers were randomly selected to 
deliver to their participants an extended version 
of the questionnaire also with the BMQ-Specific 
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questionnaire, in order to obtain more detailed 
information about patients’ beliefs about specif-
ic medications they were on, since it comprises 
two scales of assessing personal beliefs about the 
necessity of prescribed medication for controlling 
illness and concerns about the potential adverse 
consequences of medications.
Participants’ questionnaires were excluded if 
any item of BMQ was missing.
Outcome variables
We calculated mean and median scores for 
both BMQ scales and sub-scales.
For the BMQ-Specific we created four attitudi-
nal groups regarding medication, as used in previ-
ous studies [16, 17]:
•	 Sceptical (low necessity, high concerns).
•	 Indifferent (low necessity, low concerns).
•	 Ambivalent (high necessity, high concerns).
•	 Accepting (high necessity, low concerns).
Statistical analysis was conducted using SPSS 
V.24.0 and we used a significance level of 0.05.
Qualitative data collection and analysis
An open question (“What do you think about 
stopping some of the medications you are on?”) 
was used in the questionnaire. Two individual in-
vestigators coded the participants’ answers sum-
marising the content. The common codes features 
were grouped together. According to the willing-
ness to have medication deprescribed we created 
four main categories (against, in favour, indecisive 
and indifferent) and subcategories emerged from 
the answers. According to the centre for decision 
of deprescribing, three main categories (the per-




The adherence rate of GPs’ participation in the 
study was 47.7% (n = 31), but since each GP on 
average recruited 13 patients and we obtained 
403 elderly patients (386 respected the inclusion 
criteria) we stopped recruiting GPs for the study.
Of the 386 participants, 59.7% were female, 
mean age of 76.7 (95% CI: 76.0–77.4) years, and 
the mean number of drugs per person was 7.3 
(95% CI: 7.1–7.6) (Table I).
Of the 100 participants who answered the ex-
tended version of the questionnaire, 59% were fe-
male, mean age of 80.1 (95% CI: 78.5–81.7) years, 








Women 59.6 (230) 59.0 (59) 57.1 (177)
Men 40.4 (156) 41.0 (41) 42.9 (133)
Age [years]:
65 to 74 43.5 (168) 28.0 (28) 43.5 (135)
≥ 75 56.5 (218) 72.0 (72) 56.5 (175)
Education:
Low level (< 6 years) 75.1 (290) 84.0 (84) 76.1 (236)
Medium level (6 to 9 years) 13.2 (51) 10.0 (10) 13.5 (42)
High level (> 9 years) 10.9 (42) 6.0 (6) 9.4 (29)
Unknown 0.8 (3) 0.0 (0) 1.0 (3)
Perceived number of chronic health problems:
0 to 2 16.8 (65) 55.0 (55) 21.3 (66)
3 to 4 38.1 (147) 19.0 (19) 32.9 (102)
5 to 6 27.5 (106) 8.0 (8) 25.8 (80)
7 to 8 7.5 (29) 1.0 (1) 8.7 (27)
9 to 10 2.8 (11) 0.0 (0) 3.5 (11)
≥ 11 0.8 (3) 0.0 (0) 1.0 (3)
NA 6.5 (25) 17.0 (17) 6.8 (21)
Number of medications:
5 to 9 drugs 79.5 (307) 68.0 (68) 76.8 (238)
≥ 10 drugs 20.5 (79) 32.0 (32) 23.2 (72)
NA – not answered.
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Table II. Patients’ beliefs about medicines
BMQ subscale Mean (95% CI) P-value % (n) above the scale 
mid-point
General Overusea: 11.4 (11.1–11.6) 33.4 (129)g
Women 11.2 (10.8–11.6) 0.217e 31.7 (73) 
Men 11.5 (11.1–12.0) 35.9 (56)
65 to 75 years 11.1 (10.7–11.5) 0.306e 31.5 (53)
≥ 75 years 11.5 (11.1–11.9) 34.9 (76)
General Harma: 10.3 (10.0–10.6) 19.9 (77)g
Women 10.3 (9.9–10.8) 0.672e 22.2 (51)
Men 10.1 (9.6–10.5) 16.7 (26)
65 to 75 years 10.5 (10.0–10.9) 0.225e 23.2 (39)
≥ 75 years 10.1 (9.6–10.5) 17.4 (38)
Necessityb: 21.3 (20.1–22.5) 97.0 (97)h
Women 21.6 (20.9–22.3) 0.116e 96.6 (57)
Men 20.8 (20.0–21.5) 97.6 (40)
65 to 75 years 21.6 (20.6–22.6) 0.423e 96.4 (27)
≥ 75 years 21.1 (20.5–21.7) 97.2 (70)
Concernc: 17.5 (16.7–18.3) 45.0 (45)h
Women 17.3 (16.2–18.5) 0.580e 45.8 (27)
Men 17.7 (16.7–18.8) 43.9 (18)
65 to 75 years 17.5 (15.5–19.5) 0.984e 42.9 (12)
≥ 75 years 17.5 (16.7–18.3) 45.8 (33)
Necessity-concern 
differentiald:
3.8 (2.9–4.7) 74.0 (74)h
Women 4.3 (3.0–5.6) 0.171f 76.3 (45)
Men 3.0 (1.9–4.2) 70.7 (29)
65 to 75 years 4.1 (2.0–6.2) 0.631f 75.0 (21) 
≥ 75 years 3.6 (2.7–4.6) 73.6 (53)
aScale from 4 to 20 where high scores indicate higher agreement. bScale from 5 to 25 where high scores indicate higher agreement. cScale 
from 6 to 30 where high scores indicate higher agreement. dScale from -20 to 20 where positive scores indicate patient perceives that 
benefits outweigh risks. eMann-Whitney U test. fStudent’s t-test. gN = 386. hN = 100.
and the mean self-reported number of drugs per 
person was 8.1 (95% CI: 7.5–8.7). The subgroup 
that answered the BMQ-Specific was statistical-
ly significantly older (p = 0.005) and had a  low-
er number of perceived chronic health problems 
(p < 0.001) than the sample group. There were no 
statistically significant differences for the other 
variables in Table I.
BMQ analysis
Most participants (74%) believed that medi-
cines were generally beneficial. However, 19.9% 
indicated a  strong belief that medicines were 
harmful and 33.4% that they were generally over-
used (Table II).
Analysing the group of 100 participants who 
answered the extended version, we found similar 
results for the belief that medicines were harm-
ful (14.0%) and that they were generally overused 
(45.0%). 
According to the belief in the need for medi-
cation (BMQ-Specific Necessity), 97.0% agreed for 
maintaining health (score greater than the scale 
mid-point), but 45.0% were concerned about po-
tential adverse consequences of medications 
(score greater than the scale mid-point). Most of 
them (74.0%) indicated strong beliefs that the 
benefits of their medication outweighed the risks 
(the difference between the need and concern 
scores was positive). When participants were cat-
egorised by belief group, the majority were found 
to be accepting (46.0%) or ambivalent (44.0%) 
(Figure 1).
Participants’ views on deprescribing
In order to obtain the participants’ views on 
deprescribing we asked the open question “What 
do you think about stopping some of the medica-
tions you are on?”. From the 386 participants, only 
75.9% (n = 293) answered this question. From its 
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analysis we found that 61.8% (n = 181) of the pa-
tients were against the idea of deprescribing. 
– “I  don’t think it’s possible to stop medicines, 
I have to take them all.” [P327, 89 years].
In favour of the idea were 24.6% (n = 72) of the 
responders; 7.2% (n = 21) were indifferent;
– “I agree, medicines are bad.” [P402, 66 years]
– “It’s the doctor who knows.” [P21, 71 years]
– “I don’t think it’s good or bad.” [P319, 80 years]
and 6.5% (n = 19) were indecisive.
–  “I would like it, but I think they are what support 
my health.” [P105, 74 years]
–  “Yes, but I’m afraid.” [P131, 78 years]
–  “It’s hard to answer because I don’t know what the 
effect will be on the clinical level.” [P380, 76 years]
From the 181 participants who were against 
deprescription we could subcategorise 55.2% (n = 
100) of the answers. Almost half of them (41%) 
were against it because of the perception that it 
would worsen their medical condition;
–  “I can’t stop because otherwise I will die” [P36, 
76 years]
–  “There are medications that if I  quit my sys-
tem soon changes, for example cholesterol and 
tension. If I do not take the inhaler, asthma ap-
pears.” [P182, 77 years]
Thirty-one percent were against it because of 
the value they attribute to medicines;
–  “I must not stop because they are good for my 
health” [P35, 66 years]
Others, 18%, because they felt well as they were;
–  “I think not. If I feel well, there is no need to take 
away medications.” [P339, 83 years]
Six percent said that they should take it be-
cause if it was prescribed by the doctor;
–  “In my opinion I trust the doctor and I think he 
prescribes within my needs as a patient.” [P150, 
72 years]
and 4% were against it because they had al-
ready tried stopping some medications and it did 
not go well.
–  “I thought so, but I came to the conclusion that 
I am addicted to medicines.” [P15, 82 years]
–  “If you stop 2/3 days you will not notice a dif-
ference. If it is more days, problems arise.” [P70, 
75 years]
From the 72 participants who were in favour 
we could subcategorise 83.3% (n = 60) of the an-
swers. The most common reason was the willing-
ness to reduce the medication list (35%). Some 
patients said:
–  “I  would like them to be reduced. I  think it is 
possible.” [P295, 83 years]
–  “The less the better.” [P333, 93 years]
33.3% would agree to stop medication if the 
doctor told them to;
–  “I  do not do it. Only with the doctor’s indica-
tion.” [P34, 72 years]
–  “If the doctor indicates I have no problem stop-
ping the medication. On my own initiative I ex-
clude the possibility of stopping the medica-
tion.” [P93, 83 years]
–  “I liked it! But I’m scared! But if the doctor pro-
posed, I would accept it.” [P104, 88 years]
Twenty percentage if there were side effects or 
if the medication was ineffective;
–  “I agree totally. I think I need to stop it now, be-
cause, for example, I sleep a lot now.” [P318, 69 
years]
–  “I  agree if the medication is not doing well.” 
[P390, 66 years]
–  “Yes, I would like to reduce the number of med-
icines I  take as they cause unwanted effects.” 
[P400, 68 years]
and 11.7% were in favour of deprescribing be-
cause they had already tried and it went well.
–  “I  do it from time to time when I  feel better.” 
[P395, 86 years] 
–  “Sometimes I forget some because I feel good.” 
[P398, 83 years]
From 190 answers we could deduct where the 
decision centre about the idea of deprescribing 
was. In 60.5% the centre of ideas and feelings 
about medicines and deprescription was in the 
patient.
–  “There are medicines to stop, others not.” [P58, 
79 years]
–  “I  don’t want to stop any medication because 
I need them all.” [P301, 86 years]
–  “When I  am better, I  try to reduce them, but 
sometimes I have to go back to what I was pre-
scribed.” [P312, 62 years]
In 39.0% of the answers, patients put the cen-
tre of decision in the doctor and 0.5% in a third 
person.
–  “Error. I would not do it without talking with the 
physician.” [P40, 76 years]
–  “This opinion I  think belongs to the doctor.” 
[P386, 73 years]
Figure 1. Elderly patients and the idea of having 














 5 10 15 20 25
Total necessity
Sceptical 1% Ambivalent 44%
Indifferent 0% Accepting 46%
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–  “Yes, I think I take too many medications, but it 
depends on the doctor.” [P401, 91 years]
–  “I was told that I couldn’t.” [P24, 79 years]
Willingness to have medication 
deprescribed
We compared the characteristics of the group 
against the idea of being deprescribed with those 
of the group not against being deprescribed (in fa-
vour, indifferent and indecisive).
We found no significant differences according 
to age, gender or number of medications. How-
ever, we found that those against being depre-
scribed had a  lower education level (p = 0.006, 
mean difference of –1.11 years (–1.87 to –0.34)) 
and had a  higher number of perceived morbidi-
ties (p = 0.001, mean difference of +0.97 (0.41 to 
1.52)) than those not against being deprescribed.
Table III shows the differences in responses be-
tween the two groups according to BMQ (Gener-
al and Specific). We found statistically significant 
differences in statements regarding the willing-
ness to have medication deprescribed:
•	 BMQ statement 2 “People who take medicines 
should stop their treatment for a  while every 
now and again” (p < 0.001): those against hav-
ing medication deprescribed mostly disagreeing 
with the statement and those not against hav-
ing medication deprescribed agreeing with it; 
•	 BMQ statement 4 “Natural remedies are safer 
than medicines” (p = 0.047): those against hav-
ing medication deprescribed mostly disagree-
ing with the statement and those not against 
neither agreeing or disagreeing;
•	 BMQ-General Overuse (p < 0.001): those 
against having medication deprescribed mostly 
disagreeing that there was overuse of medi-
cines and those not against perceiving overuse 
of medicines;
•	 BMQ-General Harm (p = 0.003): those against 
having medication deprescribed disagreeing 
more and those agreeing to having medication 
deprescribed agreeing more with the sense of 
harm by medicines. 
There were no statistically significant differ-
ences between the two groups according to the 
needs and concerns about medication. However, 
we found that those against the idea of having 
medication deprescribed perceived that the ben-
efits of medication outweigh the risks to a higher 
degree than those not against the idea (p = 0.027, 
mean difference = 1.97 (0.22 to 3.72)).
Discussion
Strengths of the study
Combining qualitative and quantitative data 
from a  representative random sample allows 
a  richer analysis for the comprehension of the 
questions to be studied.
Statement of overall findings
This study results reveal that there was a strong 
belief in medication benefits. For 19.9% a strong 
belief that medicines were harmful and for 33.4% 
medicines were overused was perceived. Our find-
ings concerning the general harm and overuse of 
the medication were higher than those reported 
in other studies, namely compared with a  study 
in Ireland [17] reporting that only 3% of patients 
believed that the medication was harmful and 
just over 5% that it was overused. In relation to 
the BMQ-Specific, we found that 97% viewed the 
medication as necessary and 45% were concerned 
about potential adverse consequences, these re-
sults being in line with those in Ireland [17]. When 
participants were categorized by belief group, we 
found a  lower number of participants accepting 
the medication compared with Clyne et al. (46% 
vs. 63.4%) but a higher number of ambivalent par-
ticipants (44% vs. 32.6%) [17].
Overall, the literature shows rates of 85–90% 
of older adults who are willing to stop one or more 
medications [5, 20], but according to Turner et al. 
[5] from 86% willing to stop only 41% successfully 
discontinued their prescription at 6 months after 
intervention. 
No difference in the willingness to have med-
ication deprescribed according to age matches 
the literature [3–5]. However, some studies have 
found that older adults notice differences be-
tween stopping preventive medications and feel-
ing relief of symptoms. They perceived clear effi-
cacy for symptomatic relief medicines since they 
notice the symptoms anew when they reduce or 
stop medicines. However, with prophylactic or 
specific treatment medicines, the patients are not 
so easily aware of the medicines’ benefits, making 
them more prone to stop them [21–23].
Patient’s gender does not seem to affect the 
willingness to have medication deprescribed, and 
this is also in line with previous studies [3–5]. 
According to the patient’s willingness to have 
medications deprescribed, we found a  rise with 
the increased educational level, as found by pre-
vious studies [3–5]. One possible explanation is 
that people with a  higher educational level are 
more knowledgeable and able to make a  critical 
assessment of drugs, knowing that they have 
benefits and risks and that, sometimes, risks may 
outweigh their benefits. However, most of the par-
ticipants in both groups did not have more than 
6 years of education, so we cannot extrapolate to 
the other higher education levels.
Patients with a  lower number of perceived 
morbidities seem to have a  stronger willingness 
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Table III. Comparison of BMQ according to the willingness to have medication deprescribed

















G1 Against 18.2 (33) 55.2 (100) 12.7 (23) 9.4 (17) 4.5 (8) 0.177
Not against 2.7 (3) 12.5 (14) 17.0 (19) 58.9 (66) 8.9 (10)
G2 Against 22.0 (40) 37.7 (68) 15.4 (28) 19.9 (36) 5.0 (9) < 0.001
Not against 6.3 (7) 29.5 (33) 14.3 (16) 40.1 (45) 9.8 (11)
G3 Against 11.6 (21) 27.0 (49) 14.4 (26) 36.5 (66) 10.5 (19) 0.308
Not against 4.4 (5) 28.6 (32) 13.4 (15) 42.9 (48) 10.7 (12)
G4 Against 15.5 (28) 30.4 (55) 27.0 (49) 19.9 (36) 7.2 (13) 0.047
Not against 5.3 (6) 30.4 (34) 25.0 (28) 30.4 (34) 8.9 (10)
G5 Against 32.0 (58) 53.1 (96) 6.6 (12) 6.1 (11) 2.2 (4) 0.145
Not against 24.1 (27) 52.7 (59) 14.3 (16) 8.0 (9) 0.9 (1)
G6 Against 31.5 (57) 47.5 (86) 10.5 (19) 5.0 (9) 5.5 (10) 0.206
Not against 26.8 (30) 47.3 (53) 11.6 (13) 11.6 (13) 2.7 (3)
G7 Against 8.3 (15) 18.2 (33) 25.4 (46) 36.5 (66) 11.6 (21) 0.058
Not against 2.7 (3) 25.0 (28) 16.1 (18) 40.1 (45) 16.1 (18)
G8 Against 7.7 (14) 38.2 (69) 26.5 (48) 21.0 (38) 6.6 (12) 0.056
Not against 1.8 (2) 29.6 (33) 37.5 (42) 22.3 (25) 8.9 (10)
Overuse (G1, 
G4, G7, G8)
Against – 59.7 (108) 14.3 (26) 26.0 (47) – < 0.001
Not against – 40.2 (45) 10.7 (12) 49.1 (55) –
Harm (G2, G3, 
G5, G6)
Against – 72.9 (132) 17.2 (31) 9.9 (18) – 0.003
Not against – 64.3 (72) 12.5 (14) 23.2 (26) –
N1 Against – 0 (0) 4.4 (2) 95.6 (43) – 0.641
Not against – 1.8 (1) 5.5 (3) 92.7 (51) –
N2 Against – 2.2 (1) 2.2 (1) 95.6 (43) – 0.238
Not against – 5.5 (3) 9.1 (5) 85.4 (47) –
N3 Against – 0 (0) 2.2 (1) 97.8 (44) – 0.144
Not against – 3.6 (2) 9.1 (5) 87.3 (48) –
N4 Against – 0 (0) 4.4 (2) 95.6 (43) – 0.174
Not against – 5.5 (3) 9.1 (5) 85.4 (47) –
N5 Against – 0 (0) 6.7 (37) 93.3 (42) – 0.425
Not against – 3.6 (2) 5.5 (3) 90.9 (50) –
Total 
necessity
Against – 0 (0) 0 (0) 100 (45) – 0.354
Not against – 1.8 (1) 3.6 (2) 94.6 (52) –
C1 Against – 33.3 (15) 4.4 (2) 62.3 (28) – 0.487
Not against – 32.7 (18) 10.9 (6) 56.4 (31) –
C2 Against – 46.7 (21) 4.4 (2) 48.9 (22) – 0.308
Not against – 34.5 (19) 10.9 (6) 54.6 (30) –
C3 Against – 28.9 (13) 6.7 (3) 64.4 (29) – 0.824
Not against – 34.5 (19) 5.5 (3) 60.0 (33) –
C4 Against – 84.4 (38) 6.7 (3) 8.9 (4) – 0.409
Not against – 76.3 (42) 5.5 (3) 18.2 (10) –
C5 Against – 44.4 (20) 4.5 (2) 51.1 (23) – 0.284
Not against – 34.6 (19) 12.7 (7) 52.7 (29) –
C6 Against – 80.0 (36) 6.7 (3) 13.3 (6) – 0.807
Not against – 74.5 (41) 9.1 (5) 16.4 (9) –
Total concerns Against – 51.1 (23) 4.4 (2) 44.5 (20) – 0.666
Not against – 43.6 (24) 10.9 (6) 45.5 (25) –
G1 – “Doctors use too many medicines”; G2 – “People who take medicines should stop their treatment for a while every now and again”; 
G3 – “Most medicines are addictive”; G4 – “Natural remedies are safer than medicines”; G5 – “Medicines do more harm than good”; G6 
– “All medicines are poisons”; G7 – “Doctors place too much trust in medicines”; G8 – “If doctors had more time with patients they would 
prescribe fewer medicines”; N1 – “My health, at present, depends on these medicines”; N2 – “My life would be impossible without these 
medicines”; N3 – “Without these medicines I would be very ill”; N4 – “My health in the future will depend on these medicines”; N5 – “These 
medicines protect me from becoming worse”; C1 – “Having to take medicines worries me”; C2 – “I  sometimes worry about long-term 
effects of these medicines”; C3 – “These medicines are a mystery to me”; C4 – “These medicines disrupt my life”; C5 – “I sometimes worry 
about becoming too dependent on these medicines”; C6 – “These medicines give me unpleasant side effects.”
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to have medication deprescribed. Our findings do 
not corroborate those from previous studies [3–5] 
that did not find any association between self-re-
ported health and the success of being depre-
scribed. One possible explanation is that, as the 
person does not feel so sick, he does not perceive 
the need to take some of the medications, so is 
more inclined to stop it.
No difference was found in the willingness to 
have medication deprescribed according to the 
number of regular medications, and this is in line 
with the literature [3–5]. Therefore, more than the 
number of medicines a patient is taking, it is pos-
sibly the patient’s view of medications that influ-
ences the willingness to have medication depre-
scribed. 
Patient’s willingness to have medication de-
prescribed increases with higher agreement with 
BMQ-General Overuse, namely with statement 
number 4 “Natural remedies are safer than med-
icines”. This is reflected in some answers to the 
open question “What do you think about stopping 
some of the medications you are on?” – namely in 
those who want to be deprescribed. This could be 
due to general dislike of taking medications, in-
cluding feeling that medications are “unnatural”, 
wanting to be more in control of the treatment 
and, for patients taking psychiatric medication, 
the desire to be “normal” and thus reducing the 
stigma associated with medication use [24]. We 
can use these findings to help in the deprescrip-
tion of potentially inappropriate medication (those 
whose risks outweigh benefits, those with no clear 
indication or those that are not effective). A study 
found that patients’ belief in the importance of 
medications is poorly correlated with their GPs’ 
belief in their importance, highlighting the need 
for continuous dialogue between doctors and pa-
tients [25]. Therefore, doctors need to be careful 
that patients do not replace scientifically studied 
drugs with other, untested substances, whose ef-
fects and interactions may still be unknown.
Patient’s willingness to have medication de-
prescribed also increases with higher agreement 
with BMQ-General Harm, namely with statement 
number 2 “People who take medicines should stop 
their treatment for a while every now and again”. 
Compared with the answers to the open question 
“What do you think about stopping some of the 
medications you are on?”, we found that patients 
who felt they were having side effects from the 
medications, or that they were ineffective, and 
those who had already tried successfully to stop 
taking medications, were more willing to have 
medications deprescribed. This can make some 
patients stop or think about stopping some of 
their medications for a period of time when they 
feel better. As mentioned before, patients’ beliefs 
in the importance of medications correlate poorly 
with their GPs’ belief [25], and sometimes it is dif-
ficult for them to perceive the efficacy of medica-
tions, namely the ones prescribed for prophylactic 
or specific treatable conditions [21–23]. 
According to Reeve et al. [24] one of the en-
ablers of deprescribing is the fear of addiction, 
namely in those affecting the nervous system. 
However, we did not find differences according to 
statement number 3 “Most medicines are addic-
tive” of BMQ-General. 
We concluded from the answers that most pa-
tients think the decision about being deprescribed 
lies with themselves and not with their doctors 
(60.5% vs. 39.0%). This does not match other 
studies where most participants reported that 
they would like to discontinue one or more of their 
drugs if their doctor told them that they could do 
so [6, 26, 27]. A Danish survey [26] found that 85% 
of the participants would be willing to stop one or 
more of their regular medications if their doctor 
said it was possible. They also found that half of 
the participants preferred being deprescribed for 
one or more of their drugs if followed by a health-
care professional in consultation, and the other 
half of the participants would have liked phone 
or email follow-up. Another study [28] found that 
several patients did not know which medications 
they took and what their indications were be-
cause they did not give it any importance, as they 
had complete trust in the responsible healthcare 
professionals. Still some studies have found that, 
in addition to the high interest in stopping med-
ications, a significant number of patients refused 
to undergo deprescribing when it was proposed 
[29–31]. This means that if patients lack sufficient 
health literacy, they cannot make informed health 
decisions, they feel powerless, assume a passive 
attitude, and become dependent on their doctor’s 
judgement. Thus, when their GP renews the pre-
scription, they see it as a sign that they need to 
continue taking it [24], as expressed by some of 
the participants as the reason for rejecting the 
idea of being deprescribed. Interpersonal trust 
(between patient and clinician) is a key element 
of the doctor-patient relationship, especially as 
regards taking medicines, one particularly valued 
by older patients [17, 21, 24, 32–34]. So, doctor’s 
knowledge about medicines is a key subject in de-
prescribing, as it is in the prescribing process.
However, further studies are needed to better 
understand the reason why older adults consider 
that the responsibility for making a decision lies 
with them and what the reasons for that are (e.g., 
lack of information? Fear? Results not consistent 
with what they expect?) in order to increase the 
success of the deprescription.
Participants had to deliver their question-
naire to their doctor, which may have influenced 
some responses due to fear of doctor evaluation, 
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even though the questionnaires were returned in 
a closed envelope to be sent to the investigation 
team.
Not all participants answered the BMQ-Specif-
ic, and this subgroup was statistically older and 
had a  lower number of perceived chronic health 
problems than the sample, so the strength is low-
er and caution is needed when interpreting these 
results.
The presented themes emerged from open an-
swers, which do not provide so much information 
about the patient’s perspective as would result 
from an interview.
We found a  limited number of studies com-
paring elderly patients according to their desire 
to be deprescribed with the socio-demographic 
characteristics. Some studies selected mainly old-
er adults already willing to have medication de-
prescribed and compared those who successfully 
did it to those who did not succeed. Other studies 
only reported qualitative results or compared the 
desire to be deprescribed only using scales, name-
ly BMQ and PATD questionnaires. 
In conclusion, this study found a strong belief in 
medication benefits. It was also observed that the 
majority (61.8%) of the participants were against 
the idea of being deprescribed.
The categorization of the belief group shows 
that most of the participants were either accept-
ing of medication or ambivalent. We also found 
that most participants were against the idea of 
deprescribing, the most common reasons being 
the fear of worsening their medical situation, and 
the value attributed to medicines. The factors re-
lated to being against the idea of deprescribing 
were lower education level and a  worse percep-
tion of health.
In this study, a group of patients believed that 
stopping medication should be their own deci-
sion. Such a  finding requires reflection on the 
importance of trust and openness for an ethical 
dialogue relationship. Doctors need to adequately 
address the burden of patients’ medication and 
be skilful and competent for patient enablement 
and empowerment if patient centred medicine is 
to be practised.
It is important that doctors are aware of (the 
specificity of the contexts and of its consultants, 
namely in the holistic primary care setting, in or-
der to address the patients’ fears, beliefs, expecta-
tions and desires according to the explained best 
practice. 
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